FBT
PFE icon

Founders Bank & Trust’s Pfizer PFE Stock Holding History

Founders Bank & Trust’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$1.5M Sell
50,864
-1,425
-3% -$40.9K 0.79% 21
2014
Q3 		$1.47M Sell
52,289
-880
-2% -$24.7K 0.82% 20
2014
Q2 		$1.5M Sell
53,169
-105
-0.2% -$2.99K 0.83% 20
2014
Q1 		$1.62M Sell
53,274
-1,355
-2% -$40.4K 0.95% 18
2013
Q4 		$1.59M Sell
54,629
-1,681
-3% -$48.9K 0.92% 17
2013
Q3 		$1.53M Sell
56,310
-923
-2% -$25.1K 0.78% 19
2013
Q2 		$1.52M Buy
+57,233
New +$1.58M 0.81% 19

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Founders Bank & Trust's PFE Position: Q4 2014 in Review

Founders Bank & Trust reduced its Pfizer (PFE) stake by 2.7% in Q4 2014, selling an estimated $40.9K and leaving 50,864 shares worth $1.5M. The position accounts for 0.79% of the portfolio, ranked #21.

Founders Bank & Trust first reported a position in PFE in Q2 2013 and has held it in 7 quarters since. The position peaked at $1.62M in Q1 2014. 1,861 funds tracked by Wall St. Rank hold PFE as of Q4 2014.

  • Founders Bank & Trust held 50,864 shares of Pfizer worth $1.5M as of Q4 2014.
  • Founders Bank & Trust sold 1,425 Pfizer shares in Q4 2014, an estimated $40.9K.
  • Pfizer made up 0.79% of Founders Bank & Trust's portfolio in Q4 2014, its #21 holding.
  • Founders Bank & Trust first reported a position in Pfizer in Q2 2013 and has held it in 7 quarters since.
  • Founders Bank & Trust's Pfizer position peaked at $1.62M in Q1 2014.
  • 1,861 funds tracked by Wall St. Rank held Pfizer as of Q4 2014.

Based on Founders Bank & Trust's 13F filing for Q4 2014, filed 9 Feb 2015.